Floatz logo

249 assets in Head And Neck Squamous Cell Carcinoma

Therapeutic assets addressing Head And Neck Squamous Cell Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
hs-20093
Head And Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D CompanyP2CCC (48)
Interleukin 18 (Recombinant Human Mutein Clone St-067)
Head And Neck Squamous Cell Carcinoma
Simcha IL-18, Inc.P1/2CCC (48)
Modi-1 Moditope
Head And Neck Squamous Cell Carcinoma
Scancell LtdP1/2CCC (48)
Montanide Isa 51
Head And Neck Squamous Cell Carcinoma
Roswell Park Cancer InstituteP1/2CCC (48)
Pd-L1 T-Hank
Head And Neck Squamous Cell Carcinoma
ImmunityBio, Inc.P2CCC (48)
Recombinant Human Egf-Rp64K
Head And Neck Squamous Cell Carcinoma
Roswell Park Cancer InstituteP1/2CCC (48)
Sargramostim
Head And Neck Squamous Cell Carcinoma
Mayo ClinicP1/2CCC (48)
Selvigaltin
Head And Neck Squamous Cell Carcinoma
Providence Health & ServicesP2CCC (48)
Si-B003
Head And Neck Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.P2CCC (48)
Tak-500
Head And Neck Squamous Cell Carcinoma
TakedaP1/2CCC (48)
tj107
Head And Neck Squamous Cell Carcinoma
TJ Biopharma Co., Ltd.P2CCC (48)
Tocilizumab
Head And Neck Squamous Cell Carcinoma
TakedaP1/2CCC (48)
Zalifrelimab
Head And Neck Squamous Cell Carcinoma
ImmunoGenesisP1/2CCC (48)
a2b395
Head And Neck Squamous Cell Carcinoma
A2 Biotherapeutics Inc.P1/2CC (47)
ak129
Head And Neck Squamous Cell Carcinoma
AkesoP1/2CC (47)
ap203
Head And Neck Squamous Cell Carcinoma
AP Biosciences Inc.P1/2CC (47)
bi 765063
Head And Neck Squamous Cell Carcinoma
Boehringer IngelheimP1CC (47)
Ezabenlimab
Head And Neck Squamous Cell Carcinoma
Boehringer IngelheimP1CC (47)
mt-4561
Head And Neck Squamous Cell Carcinoma
Tanabe Pharma America, Inc.P1/2CC (47)
Penpulimab
Head And Neck Squamous Cell Carcinoma
AkesoP1/2CC (47)
pf-07257876
Head And Neck Squamous Cell Carcinoma
PfizerP1CC (47)
Fulvestrant
Head And Neck Squamous Cell Carcinoma
Terremoto Biosciences Inc.P1/2CC (46)
Obinutuzumab
Head And Neck Squamous Cell Carcinoma
Simcha IL-18, Inc.P1/2CC (46)
Spartalizumab
Head And Neck Squamous Cell Carcinoma
SOLTI Breast Cancer Research GroupP2CC (46)
Zimberelimab
Head And Neck Squamous Cell Carcinoma
Arcus Biosciences, Inc.P1CC (46)
Bms-936558-01
Head And Neck Squamous Cell Carcinoma
Bristol-Myers SquibbP1/2CC (45)
Cjrb-101
Head And Neck Squamous Cell Carcinoma
CJ Bioscience, Inc.P1/2CC (45)
Dcsz11
Head And Neck Squamous Cell Carcinoma
West China HospitalP1/2CC (45)
gen1042
Head And Neck Squamous Cell Carcinoma
GenmabP1/2CC (45)
Gtaexs617
Head And Neck Squamous Cell Carcinoma
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.P1/2CC (45)
Immunoglobulin G1 [De-C-Terminal-Lysine], Anti-(Human Cc Chemokine Receptor Ccr8) (Human-Mus Musculus Monoclonal Bms-986340 ?1-Chain), Disulfide With Human-Mus Musculus Monoclonal Bms-986340 ?-Chain, Dimer
Head And Neck Squamous Cell Carcinoma
Bristol-Myers SquibbP1/2CC (45)
jk08
Head And Neck Squamous Cell Carcinoma
Salubris Biotherapeutics IncP1/2CC (45)
Mdna11
Head And Neck Squamous Cell Carcinoma
Medicenna Therapeutics, Inc.P1/2CC (45)
ngm707
Head And Neck Squamous Cell Carcinoma
NGM Biopharmaceuticals, IncP1/2CC (45)
Petosemtamab
Head And Neck Squamous Cell Carcinoma
Merus B.V.P1/2CC (45)
Pumitamig
Head And Neck Squamous Cell Carcinoma
Bristol-Myers SquibbP1/2CC (45)
sbt6290
Head And Neck Squamous Cell Carcinoma
Silverback TherapeuticsP1/2CC (45)
t3011
Head And Neck Squamous Cell Carcinoma
ImmVira Pharma Co. LtdP1/2CC (45)
th9619
Head And Neck Squamous Cell Carcinoma
One-carbon Therapeutics ABP1/2CC (45)
Tub-030
Head And Neck Squamous Cell Carcinoma
Tubulis GmbHP1/2CC (45)
ucb4594
Head And Neck Squamous Cell Carcinoma
Cancer Research UKP1/2CC (45)
vv1
Head And Neck Squamous Cell Carcinoma
Vyriad, Inc.P2CC (45)
xnw5004
Head And Neck Squamous Cell Carcinoma
Evopoint Biosciences Inc.P1/2CC (45)
bi 836880
Head And Neck Squamous Cell Carcinoma
Boehringer IngelheimP1CC (44)
Dazostinag
Head And Neck Squamous Cell Carcinoma
TakedaP1CC (44)
Ganciclovir
Head And Neck Squamous Cell Carcinoma
Gene Surgery LLCP1CC (44)
Incb106385
Head And Neck Squamous Cell Carcinoma
Incyte CorporationP1CC (44)
Retifanlimab
Head And Neck Squamous Cell Carcinoma
Incyte CorporationP1CC (44)
Sigvotatug Vedotin
Head And Neck Squamous Cell Carcinoma
Seagen, a wholly owned subsidiary of PfizerP1CC (44)
Stimotimagene Copolymerplasmid
Head And Neck Squamous Cell Carcinoma
Gene Surgery LLCP1CC (44)
Showing 51 to 100 of 249 assets
PreviousPage 2 of 5Next